Pensioners seven times more likely to get deadly skin cancer than 40 years ago
People over 65 are around seven times more likely to develop malignant melanoma compared to 40 years ago, according to new figures released by Cancer Research UK recently (Monday).
Older men in Great Britain are around 10 times more likely to be diagnosed with this kind of life-threatening skin cancer than their parents’ generation while older women are around five times more likely to develop this disease.*
The most recent figures show that on average around 5,700 pensioners are now diagnosed with melanoma each year compared with just 600 in the mid 1970s.**
While age is one of the biggest risk factors for melanoma the huge increase in pensioners being diagnosed with the disease is likely to be linked to the cheap package holiday boom dating from the 1960s, and the desirability of having a tanned appearance even at the expense of painful sunburn.
Getting sunburnt just once every two years can triple your risk of developing malignant melanoma and even reddening of the skin is a sign of damage.
Sue Deans, a 69-year-old retired teacher and mother of three, was first diagnosed in 2000 with malignant melanoma after the doctor removed a mole, and re-diagnosed in 2007 after she discovered a lump under her armpit.
“I was part of the generation where package holidays became affordable and you could go abroad nearly every year,” she said. “I don’t think there was much understanding at the time about the impact that too much sun can have on your risk of getting skin cancer. And I loved the sun but suffered quite a bit of sunburn over the years.
“I’ve always been quite body aware so my cancer was spotted early. I had successful surgery and have been healthy since – but I’m always vigilant in keeping an eye out for anything unusual or persistent that might need to be checked. Now I make sure my grandson knows the dangers of getting caught out in the sun.”
Around 13,300 people are diagnosed with malignant melanoma in the UK each year making it the fifth most common cancer overall in the UK and the second most common cancer in young adults (aged 15-34). Each year 2,100 people die from the disease.
Professor Richard Marais, Cancer Research UK's skin cancer expert based in Manchester, said: "It's worrying to see melanoma rates increasing at such a fast pace, and across all age groups. It is very important for people to take care of their skin in the sun. It is also important for them to keep an eye on their skin and seek medical opinion if they see any changes to their moles, or even to normal areas of skin. Melanoma is often detected on men's backs and women's legs but can appear on any part of the body."
Cancer Research UK and NIVEA SUN are working in partnership to encourage people to enjoy the sun safely this summer. The partnership offers simple advice that people can follow to make sure they have a great summer while protecting their skin.
Dr Julie Sharp, Cancer Research UK’s head of health information, said: “Many cases of malignant melanoma, the most serious form of skin cancer, are preventable by taking precautions in the sun and making sure you don’t burn.
“Sun damage accumulates over time so avoiding sunburn – and sunbeds - is key as well as getting to know your skin type so you don’t overdo it on the beach or even in the garden. You can burn at home just as easily as you can on holiday, so remember to spend time in the shade, wear a T shirt and a hat to protect your skin and regularly apply sunscreen that is at least Factor 15 and has four stars. Swapping bad sun habits for good ones could save your life.”
For media enquiries contact the Cancer Research UK press office on 020 3469 8300 or, out of hours, on 07050 264 059.
Notes to Editor
* Malignant Melanoma incidence rates in people aged 65 and over in Great Britain
To remove the effects of random variations in rates from year to year the percentage change in rates since the mid 1970s is based on European age-standardised incidence rates for 1975-1977 and 2009-2011.
**Data is for Great Britain with 608 cases per year in 1975-1977 and 5,749 cases per year in 2009-2011.
More information regarding malignant melanoma available here: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/skin/
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
CRUK - Two clinical trials show promise with different targeted drugs for lung cancer07/06/2017 14:10:00
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available, according to unpublished clinical trials.
CRUK - New chemotherapy approach offers breast cancer patients a better quality of life07/06/2017 12:10:00
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.
CRUK - Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent06/06/2017 10:35:00
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine on Saturday.
British Red Cross - Manchester attack – What happens after05/06/2017 16:15:00
An edition of the BRC’s Newsthink encourages young people to consider ways that the public helped each other after the explosion. It also explores the role of practical help and emotional support during and after an emergency.